Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia

AIDS

Volumn 21, Issue 12, 2007, Pages 1631-1636

  Melendez Morales, Lehida ^a,b   Konkle, Barbara A ^c   Preiss, Liliana ^d   Zhang, Mingdong ^a,e   Mathew, Prasad ^f   Eyster, M Elaine ^g   Goedert, James J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d RTI INTERNATIONAL   (United States)

^e CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^f UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^g PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Hemophilia; Hepatitis B virus (HBV); Hepatitis C virus (HCV)

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHI SQUARE TEST; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; HEMOPHILIA; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPERINFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CD4 LYMPHOCYTE COUNT; FEMALE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; REMISSION, SPONTANEOUS; RNA, VIRAL; VIRAL LOAD;

EID: 34447574626     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32826fb6d9     Document Type: Article

References (17)

1. Goedert JJ, Eyster ME, Lederman MM, Mandalaki T, de Moerloose P, White GC, et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002; 100:1584-1589.
2. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993; 81:412-418.
3. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1993; 6:602-610.
4. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84:1020-1023.
5. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284:450-456.
6. Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots WK, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 2001; 26:466-472.
7. Eyster ME, Sanders J, Goedert JJ. Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophilia. Haemophilia 2004; 10:75-80.
8. Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003; 37:60-64.
9. Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, et al. Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 2006; 107:892-897.
10. Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, et al. Protection against persistence of hepatitis C. Lancet 2002; 359:1478-1483.
11. Goedert JJ. Prevalence of conditions associated with human immunodeficiency hepatitis virus infections among persons with haemophilia, 2001-2003. Haemophilia 2005; 11:516-528.
12. Kroner BL, Rosenberg PS, Aledort LM, Alvord WG, Goedert JJ. HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1994; 7:279-286.
13. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA 2004; 292:251-265.
14. Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr 2003; 33:356-364.
15. Eyster ME, Sanders JC, Battegay M, Di Bisceglie AM. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C. Dig Dis Sci 1995; 40:1583-1588.
16. Piasecki BA, Lewis JD, Reddy KR, Bellamy SL, Porter SB, Weinrieb RM, et al. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 2004; 40:892-899.
17. Goedert JJ, Chen BE, Preiss L, Aledort LM, Rosenberg PS. Reconstruction of the hepatitis C virus epidemic in the U.S. hemophilia population, 1940-1990. Am J Epidemiol 2007; 165:1443-1453.